9 Canadian Cannabis Stocks To

Canadian marijuana stocks continue to break out and this rally has shown no signs of slowing down.

Earlier this week, the Canadian marijuana sector received a major boost after the House Standing Committee on Health approved an amendment to Canada’s legalization bill that would allow edibles.

Legalization of Edibles Create Another Catalyst for Canada

Over the last month, Canadian licensed marijuana producers have been one of the hottest places to invest and we have seen a lot of capital enter the market during this time.

Just by looking in the average increase in trading volume on a month-over-month basis, you would see that these companies have attracted a lot of new money. A majority of this volume has been on the buy side and this has caused momentum to surge higher.

Currently, Canopy Growth (TWMJF), Aphria (APHQF), and Supreme Pharmaceuticals (SPRWF) are trading at overbought levels, while Organigram (OGRMF), Cronos (PRMCF), Aurora (ACBFF), and Emblem (EMMBF) are trading right below overbought levels.

We are favorable on this trend and look back to the fourth quarter of 2016 to find a similar trend. If this rally is anything like what we saw last year, this could just be the start of a big cycle turn.

9 Canadian Marijuana Company Developments to Know

Today, we have highlighted 9 Canadian marijuana stock updates that we believe investors need to be aware of:

  1. Emblem Corp. (EMC.V) (EMMBF) traded higher after the company announced a collaboration and licensing agreement with Toronto based Canntab Therapeutics, which has developed a patent-pending oral sustained release formulation for cannabinoids. The companies will collaborate on the pre-clinical formulation, clinical development, regulatory approval, manufacturing and commercialization of the sustained release product.
  2. Shares of Canabo Medical (CMM.V) (CAMDF) broke out of its prior trading range after the company announced that it was cash flow positive in August and anticipates continued growth for the remainder of the fourth quarter. During August, the company saw more than 1,270 new patient appointments, a new company record. Canabo physicians seeing 3,000+ new and recheck patients monthly and expecting total patient appointments for fiscal 2017 to exceed 50,000.
  3. DOJA Cannabis Limited (DOJA.CN) jumped higher after the company announced that its arm’s length offer to acquire a 22,580 sq. ft. building has been approved. Upon completion of the build-out of the new facility, DOJA’s total cannabis production capacity is expected to surpass 5,000 kg per year. We are favorable on this update and will keep an eye on how the rally continues.
  4. Maricann Group Inc. (MARI.CN) (MRRCF) has been one of the top performing marijuana stocks recently. Earlier this week, the licensed marijuana producer announced the appointment of Scott Langille as CFO, effective as of October 2nd. He has over 30 years of experience in the pharmaceutical industry in both Canada and the United States. He was formerly CFO of Tribute Pharmaceuticals Canada, which was sold to Pozen last year for $160 million.
  5. ICC International Cannabis Corporation (ICC.V) (ICCLF) has been trading higher after the company issued an update on its cannabinoid business segment. ICC recently received regulatory approval from the Ministry of Livestock, Agriculture and Fishery to import two strains of hemp with CBD flower content exceeding 10%. The authorization also permits ICC to sow, harvest and export the CBD oils, CBD extracts, and pure CBD crystals produced from these two strains. The company intends to produce and export high quality CBD extracts and crystal compounds to the growing medicinal and nutraceutical markets globally where lawful.
  6. Future Farm Technologies (FFT.CN) (FFRMF) traded significantly higher after the company’s subsidiary, FFM Consulting Services, sold 3,525 grams of crude cannabis oil from the California oil extraction facility. The sale was made to a large distributor with whom the company is now negotiating a supply contract for 100-250 kilos of oil per week. We are favorable on this transaction and believe it is a significant milestone for the company. We will keep an eye on how the shares trade from here.
  7. Ahead of the legalization of recreational marijuana in Canada, Cronos Group Inc. (MJN.V) (PRMCF) announced the rebranding of In The Zone to Original BC Ltd. The name change reflects the company’s strategic vision in anticipation of the expected legalization of recreational cannabis in Canada. OGBC will serve as the platform that Cronos will leverage to launch new brands to serve the international recreational market. OGBC is located on 31 acres of land in the Okanagan Valley in British Columbia and is focused on quality and integrity. Over the past year, manufacturing upgrades to the initial pilot facility and methodology refinements have resulted in substantial increases in both yields and quality.
  8. Isodiol International (ISOL.CN) (ISOLF) received a favorable response from the market after the company officially initiated the approval process to begin exporting its flagship product, Isoderm to Chile. In 2015, Chile legalized the use of medicinal marijuana and Isodiol is one of the first companies to register a CBD product with the Chilean Health Department. The company anticipates the introduction of additional products into the Chilean market including new non-cannabis derived CBD products.
  9. MedReleaf Corp. (LEAF.TO) (MEDFF) edged higher after the licensed marijuana producer was the first to launch a topical cream. The product is specifically formulated to provide superior absorption with MedReleaf’s award-winning high CBD strain and was developed in response to patient feedback for topical applications of CBD. MedReleaf’s topical cream uses cosmetic grade ingredients; is approved by Health Canada for sale; and is currently available at a special introductory price to allow as many patients as possible to experience this exciting new product.

Source: Technical 420

9 Canadian Cannabis Stocks To

Canadian cannabis stocks moved considerably higher yesterday after it was reported that the Canadian government will introduce legislation to legalize recreational cannabis on Thursday.

Per an article posted by CBC News, a senior government source said the proposed federal legislation to legalize and regulate cannabis will be discussed in the House of Commons on Thursday.

Expect to Follow Guidance from Federal Task Force

In December, a Federal task force released its recommendations for the legalization and regulation of recreational cannabis and many expect the government to listen to the guidance provided by the task force.

The task force’s report was prepared by a nine-person committee that worked together since June. The task force received online submissions from almost 30,000 Canadians as well as input from other countries, including Uruguay and the United States. Some of the recommendations from the task force include:

  • Apply the system currently in place for medical cannabis for recreational cannabis
  • Allowance of personal cultivation (up to four plants per residence)
  • A minimum age of 18 (provinces and territories can set a higher age limit)
  • Use the same tax system for both medical and recreational cannabis
  • Place a higher tax high potency products to discourage their use by the general public

Horizon’s Cannabis ETF Jumps 10%

Last week, Horizon’s Medical Marijuana Life Sciences ETF commenced trading on the Toronto Stock Exchange under the ticker symbol HMMJ. The ETF is up more than 16% since it started trading and momentum is trending higher.

HMMJ was designed to provide exposure to a basket of publicly traded companies levered to the North American cannabis industry and yesterday’s rally caused the ETF to rally approximately 10%.

We are favorable on the reaction to yesterday’s announcement and will monitor how the market responds today. Investors should keep an eye on HMMJ as it will provide insight into the strength of the North America cannabis industry.

9 Stocks to Watch

We remain bullish on the Canadian cannabis industry and plan to increase our leverage to specific companies and sub-sectors prior to Thursday’s announcement.

We want to highlight 9 stocks that we believe investors should have on their radar ahead of Thursday’s announcement: Cronos Group (MJN.V) (PRMCF), Emblem Corp (EMC.V) (EMMBF), OrganiGram Holding (OGI.V) (OGRMF), Canopy Growth (WEED.TO) (TWMJF), Aphria (APH.TO) (APHQF), CanniMed Therapeutics Inc. (CMED.TO) (CMMDF), Aurora Cannabis (ACB.V) (ACBFF), Canabo Medical (CMM.V) (CAMDF), and Invictus MD Strategies Corp. (IMH.V) (IVITF).

Become a Technical420 Premium Member to learn more!

Important Investor Disclosures

Disclosure. Compensated Affiliate. This report was authored by and is property of Technical420. All information and data relied upon in drafting this report is publicly available. The author believes and considers its sources to be reliable, but does not guarantee the accuracy or completeness of any information contained in this report. Any and all information, data, analyses and opinions are provided for informational purposes only and is not intended, in any manner, as investment advice. Any projections or other information generated by Technical420 regarding the likelihood of various investment outcomes are hypothetical in nature, do not reflect actual investment results, and are not guarantees of future results. None of the material contained in this report is intended as a solution or offer to sell or purchase a specific stock or any other investment. This report is not directed to, or intended for distribution or use by, any person or entity that is a citizen, resident or located in any municipality, state, country or other jurisdiction where the distribution, publication, availability, or use of this report is contrary to any governing law or regulation. The securities discussed in this report may not be eligible for purchase and/or sale in certain jurisdictions or by particular individuals. It is important that you check any and all governing laws and/or regulations that may be applicable in your jurisdiction. Investing in securities of issuers organized outside of the United States, including ADRs, entail certain risks. The securities of non-United States issuers may not be registered with, nor be subject to the reporting requirements of the United States Securities and Exchange Commission. Please contact a Financial Advisor for professional advice regarding any and all securities investments. This report is intended for informational purposes only. Technical420’s officers, directors, employees, affiliates, or subsidiaries may have positions in securities covered by Technical420. Technical420 may receive compensation from the company and/or has a position in the securities mentioned in this report

Source: Technical 420